Drug recall D-0581-2018
Product
Methylphenidate Hydrochloride Extended-release Tablets, USP, 36 mg, 100-count bottle, Rx only, Trigen Laboratories, LLC Bridgewater, NJ 08807. NDC 13811-708-10
Reason for recall
Subpotent Drug:100-count product bottle labeled as Methylphenidate HCL ER Tablets 36 mg found to contain 1 27 mg Methylphenidate HCL ER Tablet.
Lots and codes
Lots: 170231B, 170232A, 170233A, 170234A
Recall details
- Recalling firm
- Osmotica Pharmaceutical Corp, Marietta, GA
- Quantity
- 19,664 100-bottles
- Distribution
- Nationwide in the USA
- Type
- Voluntary: Firm initiated
- Recall initiated
- February 28, 2018
- Terminated
- May 1, 2019
Related products
- Methylphenidate Hydrochloride – drug information
- NDC 13811-708 Methylphenidate Hydrochloride · Methylphenidate Hydrochloride 36 mg/1 · Trigen Laboratories, LLC
- NDC 13811-710 Methylphenidate Hydrochloride · Methylphenidate Hydrochloride 72 mg/1 · Trigen Laboratories, LLC
- NDC 13811-707 Methylphenidate Hydrochloride · Methylphenidate Hydrochloride 27 mg/1 · Trigen Laboratories, LLC
- NDC 13811-706 Methylphenidate Hydrochloride · Methylphenidate Hydrochloride 18 mg/1 · Trigen Laboratories, LLC
- NDC 13811-709 Methylphenidate Hydrochloride · Methylphenidate Hydrochloride 54 mg/1 · Trigen Laboratories, LLC